OTC Pharmaceuticals in France

OTC Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the France otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to buy

_x005F What was the size of the France otc pharmaceuticals market by value in 2015

_x005F What will be the size of the France otc pharmaceuticals market in 2020

_x005F What factors are affecting the strength of competition in the France otc pharmaceuticals market

_x005F How has the market performed over the last five years

_x005F Who are the top competitors in France's otc pharmaceuticals market

Companies mentioned

Johnson & Johnson

The Procter & Gamble Company

Reckitt Benckiser Group plc

Sanofi SA

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market share

Market distribution

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Johnson & Johnson

The Procter & Gamble Company

Reckitt Benckiser Group plc

Sanofi SA

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: France OTC pharmaceuticals market value: $ million, 201115

Table 2: France OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: France OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 4: France OTC pharmaceuticals market share: % share, by value, 2015

Table 5: France OTC pharmaceuticals market distribution: % share, by value, 2015

Table 6: France OTC pharmaceuticals market value forecast: $ million, 201520

Table 7: Johnson & Johnson: key facts

Table 8: Johnson & Johnson: key financials ($)

Table 9: Johnson & Johnson: key financial ratios

Table 10: The Procter & Gamble Company: key facts

Table 11: The Procter & Gamble Company: key financials ($)

Table 12: The Procter & Gamble Company: key financial ratios

Table 13: Reckitt Benckiser Group plc: key facts

Table 14: Reckitt Benckiser Group plc: key financials ($)

Table 15: Reckitt Benckiser Group plc: key financials (£)

Table 16: Reckitt Benckiser Group plc: key financial ratios

Table 17: Sanofi SA: key facts

Table 18: Sanofi SA: key financials ($)

Table 19: Sanofi SA: key financials (€)

Table 20: Sanofi SA: key financial ratios

Table 21: France size of population (million), 201115

Table 22: France gdp (constant 2005 prices, $ billion), 201115

Table 23: France gdp (current prices, $ billion), 201115

Table 24: France inflation, 201115

Table 25: France consumer price index (absolute), 201115

Table 26: France exchange rate, 201115

List of Figures

Figure 1: France OTC pharmaceuticals market value: $ million, 201115

Figure 2: France OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 4: France OTC pharmaceuticals market share: % share, by value, 2015

Figure 5: France OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 6: France OTC pharmaceuticals market value forecast: $ million, 201520

Figure 7: Forces driving competition in the OTC pharmaceuticals market in France, 2015

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015

Figure 13: Johnson & Johnson: revenues & profitability

Figure 14: Johnson & Johnson: assets & liabilities

Figure 15: The Procter & Gamble Company: revenues & profitability

Figure 16: The Procter & Gamble Company: assets & liabilities

Figure 17: Reckitt Benckiser Group plc: revenues & profitability

Figure 18: Reckitt Benckiser Group plc: assets & liabilities

Figure 19: Sanofi SA: revenues & profitability

Figure 20: Sanofi SA: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports